Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
No microdose tiers, oral tablets, or liquid drops are available for either semaglutide or tirzepatide
Most patients report reduced food cravings, improved portion control, and sustained energy throughout the daychanges that accumulate into meaningful weight reduction over months
What are the potential benefits and side effects of taking L-carnitine supplements
A team of researchers at the University of Bern, Switzerland, recently reported that the use of the antidiabetic medicine semaglutide is associated with an increased risk of vision impairment